Medtronic Neuromodulation: Device Recall

Recall Details

Recall Number

Z-3073-2024

Classification

Class II

Product Type

Device

Recalling Firm

Medtronic Neuromodulation

Status

Ongoing

Date Initiated

06/17/2024

Location

Minneapolis, MN, United States

Voluntary/Mandated

Voluntary: Firm initiated

Product Quantity

211 devices

Reason for Recall

A subset of the handsets within the kit may not be able to complete the pairing process with the communicator upon initial setup.

Product Description

Medtronic Handset with Communicator, Model TH90Q01, InterStim Smart Programmer and Communicator Kits, containing the Model HH90 Handset and the TM90 Communicator.

Distribution Pattern

US Nationwide distribution.

Other Recalls by Medtronic Neuromodulation

• Class II: Risk 12/03/2025
  Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.
• Class II: Risk 11/20/2025
  Software issue where a Device Reset message displayed on the app was unable to be cleared. In rare cases, this resulted in an inability to resume therapy, and the patient experienced a recurrence of underlying pain symptoms. Resolution would require surgical replacement of the INS.
• Class II: Risk 04/03/2025
  Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms (e.g. overactive bladder, urinary retention, or fecal incontinence) based on their response to stimulation during the evaluation period.
• Class II: Risk 03/04/2025
  There is a software issue that can permanently disable communication with an implantable neurostimulator (INS) when a specific intraoperative programming sequence is used.
• Class II: Risk 01/09/2025
  Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.

View all recalls by Medtronic Neuromodulation →